MX2022011641A - Detección rápida implementable en campo del virus sars-cov-2. - Google Patents

Detección rápida implementable en campo del virus sars-cov-2.

Info

Publication number
MX2022011641A
MX2022011641A MX2022011641A MX2022011641A MX2022011641A MX 2022011641 A MX2022011641 A MX 2022011641A MX 2022011641 A MX2022011641 A MX 2022011641A MX 2022011641 A MX2022011641 A MX 2022011641A MX 2022011641 A MX2022011641 A MX 2022011641A
Authority
MX
Mexico
Prior art keywords
cov
sars
virus
rapid field
quantify
Prior art date
Application number
MX2022011641A
Other languages
English (en)
Inventor
Jennifer A Doudna
Melanie Ott
Parinaz Fozouni
Daniel A Fletcher
David Savage
Emeric Charles
Sungmin Son
Gagandeep Renuka Kumar
Neil Switz
Original Assignee
The J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone filed Critical The J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone
Publication of MX2022011641A publication Critical patent/MX2022011641A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6825—Nucleic acid detection involving sensors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N2021/6463—Optics
    • G01N2021/6469—Cavity, e.g. ellipsoid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente divulgación se refiere a métodos que usan la enzima CRISPR-Cas13, en complejo con los ARN guía de ARNcr del SARS-CoV-2 para detectar y cuantificar la presencia del ARN del SARS-CoV-2 en una muestra con especificidad y sensibilidad mejoradas. Estos métodos se pueden usar para diagnosticar la infección por SARS-CoV-2, cuantificar la concentración de ARN de SARS-CoV-2 presente en una muestra, identificar la presencia de diferentes variantes, subtipos o mutaciones de empalme de SARS-CoV-2 y monitorear reactivación de la transcripción del SARS-CoV-2.
MX2022011641A 2020-03-19 2021-03-18 Detección rápida implementable en campo del virus sars-cov-2. MX2022011641A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202062991827P 2020-03-19 2020-03-19
US202063057082P 2020-07-27 2020-07-27
US202062706488P 2020-08-19 2020-08-19
US202063081168P 2020-09-21 2020-09-21
US202163158297P 2021-03-08 2021-03-08
PCT/US2021/023025 WO2021188830A2 (en) 2020-03-19 2021-03-18 RAPID FIELD-DEPLOYABLE DETECTION OF SARS-CoV-2 VIRUS

Publications (1)

Publication Number Publication Date
MX2022011641A true MX2022011641A (es) 2022-12-08

Family

ID=77771406

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022011641A MX2022011641A (es) 2020-03-19 2021-03-18 Detección rápida implementable en campo del virus sars-cov-2.

Country Status (12)

Country Link
US (1) US20210348243A1 (es)
EP (1) EP4121568A2 (es)
JP (1) JP2023520754A (es)
KR (1) KR20230003470A (es)
CN (1) CN116438303A (es)
AU (1) AU2021236681A1 (es)
BR (1) BR112022018769A2 (es)
CA (1) CA3178847A1 (es)
IL (1) IL296569A (es)
MX (1) MX2022011641A (es)
WO (1) WO2021188830A2 (es)
ZA (1) ZA202211358B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113699148B (zh) * 2021-07-15 2024-01-09 四川大学 一种超灵敏抗体检测方法
US11814689B2 (en) 2021-07-21 2023-11-14 Montana State University Nucleic acid detection using type III CRISPR complex
CN113817873A (zh) * 2021-09-30 2021-12-21 华南理工大学 一种用于新冠病毒d614g突变的检测方法及试剂盒
US20230167485A1 (en) * 2021-11-29 2023-06-01 Microsoft Technology Licensing, Llc Multiplex assay for nucleic acid detection
CN113913406B (zh) * 2021-12-14 2022-04-08 中国人民解放军军事科学院军事医学研究院 一种用于检测SARS-CoV-2 69:70del位点的方法
CN114236124B (zh) * 2021-12-16 2023-06-09 军事科学院军事医学研究院环境医学与作业医学研究所 一种基于等温扩增和Cas14a双重放大的检测肌酸激酶同工酶的试剂盒
CN114350854B (zh) * 2022-01-10 2023-08-01 中国人民解放军军事科学院军事医学研究院 一种基于RAA-CRISPR检测SARS-CoV-2 69-70del位点的方法
CN114807316B (zh) * 2022-03-11 2023-02-03 北京科技大学 一种无核酸扩增可视化的rna定量检测方法
WO2023201275A1 (en) * 2022-04-13 2023-10-19 The Board Of Trustees Of The Leland Stanford Junior University Enzyme kinetics analyses of crispr endonucleases
WO2023235887A1 (en) * 2022-06-03 2023-12-07 Tpb Management Llc Computational multiplexing and application thereof
WO2024011208A1 (en) 2022-07-08 2024-01-11 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone VIRAL DIAGNOSTIC USING CRISPR RNA COMBINATIONS AND Cas13a ENZYME
WO2024091905A2 (en) * 2022-10-27 2024-05-02 University Of Rochester Compositions, methods and systems for high-fidelity cas13a variants with improved specificity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867851B2 (en) * 1999-11-04 2005-03-15 Regents Of The University Of Minnesota Scanning of biological samples
US7593157B2 (en) * 2004-11-29 2009-09-22 Nikon Corporation Zoom microscope
US7813013B2 (en) * 2006-11-21 2010-10-12 Illumina, Inc. Hexagonal site line scanning method and system
US20090162863A1 (en) * 2007-12-13 2009-06-25 Hitachi High-Technologies Corporation Nucleic acid detection probe
US10337051B2 (en) * 2016-06-16 2019-07-02 The Regents Of The University Of California Methods and compositions for detecting a target RNA
WO2020051452A2 (en) * 2018-09-07 2020-03-12 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone Hiv or hcv detection with crispr-cas13a

Also Published As

Publication number Publication date
KR20230003470A (ko) 2023-01-06
IL296569A (en) 2022-11-01
CA3178847A1 (en) 2021-09-23
AU2021236681A1 (en) 2022-11-17
BR112022018769A2 (pt) 2022-12-20
ZA202211358B (en) 2024-02-28
EP4121568A2 (en) 2023-01-25
CN116438303A (zh) 2023-07-14
WO2021188830A2 (en) 2021-09-23
JP2023520754A (ja) 2023-05-19
US20210348243A1 (en) 2021-11-11
WO2021188830A3 (en) 2021-11-11

Similar Documents

Publication Publication Date Title
ZA202211358B (en) Rapid field-deployable detection of sars-cov-2 virus
WO2020051452A3 (en) Hiv or hcv detection with crispr-cas13a
Hurt et al. Performance of six influenza rapid tests in detecting human influenza in clinical specimens
EA202090277A2 (ru) Применение размера фрагмента бесклеточной днк для определения вариаций числа копий
EA201171046A1 (ru) Зонды и праймеры для детектирования вируса чикунгуньи
ATE541057T1 (de) Primer und sonden für den nachweis und die unterscheidung von typen und subtypen des influenzavirus
CY1114111T1 (el) Μεθοδοι χρησης του mirna για την ανιχνευση του in vivo θανατου των κυτταρων
MY188333A (en) Enzymatic preparation containing thermostable dna polymerase, process for producing same, and method for detecting analyte organism
NZ701972A (en) Test strip and detecting device
PH12017500798A1 (en) Pna probes, kits and methods for detecting human papillomavirus genotypes of human papillomavirus
MY193521A (en) Method for detecting audio signal and apparatus
MX2022009783A (es) Ensayo de proximidad.
Amendola et al. Standardization and performance evaluation of “modified” and “ultrasensitive” versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia
MX2021009094A (es) Metodos y sistemas para la deteccion rapida de listeria utilizando agentes infecciosos.
EP2585832A4 (en) REDUCTION OF INCORRECT RESULTS OF TEST MEASUREMENTS
MX2020007054A (es) Metodos y sistemas para la rapida deteccion de cronobacter utilizando agentes infecciosos.
Schønning et al. Analytical and clinical performance of the Hologic Aptima HCV Quant Dx assay for the quantification of HCV RNA in plasma samples
CN103243181A (zh) 甲型h7n9流感病毒检测试剂盒及检测方法
ATE431549T1 (de) Verfahren zur kapazitiven detektion von fehlstellen in polymerrohren und vorrichtung
MX2023009414A (es) Metodos para detectar una cadena ligera de neurofilamento en plasma y fluido cefalorraquideo.
CN104152581A (zh) 汉城型汉坦病毒的Taqman探针荧光定量快速检测方法
Duncan et al. Analytical and clinical validation of novel real-time reverse transcriptase–polymerase chain reaction assays for the clinical detection of swine-origin H1N1 influenza viruses
MX2023001973A (es) Sistema y métodos de detección de oncarn para diagnóstico de cáncer.
Wang et al. Sputasol (dithiothreitol 0.54%) improves the detection of human papillomaviruses using the cobas 4800 system
Genova-Kalou et al. EVALUATION OF INTERACTIONS OF SARS-COV-2 STRUCTURAL PROTEINS WITH SPECIFIC ANTIBODIES BY SPR ASSAY